NO177425C - Analogifremgangsmåte for fremstilling av terapeutisk aktive interfenylen-7-oksabicyklo-heptyl-substituerte heterocykliske amid-prostaglandinanaloger - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive interfenylen-7-oksabicyklo-heptyl-substituerte heterocykliske amid-prostaglandinanaloger

Info

Publication number
NO177425C
NO177425C NO901494A NO901494A NO177425C NO 177425 C NO177425 C NO 177425C NO 901494 A NO901494 A NO 901494A NO 901494 A NO901494 A NO 901494A NO 177425 C NO177425 C NO 177425C
Authority
NO
Norway
Prior art keywords
interphenylene
aralkyl
aryl
oxabicycloheptyl
prostaglandin analogs
Prior art date
Application number
NO901494A
Other languages
English (en)
Norwegian (no)
Other versions
NO177425B (no
NO901494L (no
NO901494D0 (no
Inventor
Raj Narain Misra
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NO901494D0 publication Critical patent/NO901494D0/no
Publication of NO901494L publication Critical patent/NO901494L/no
Publication of NO177425B publication Critical patent/NO177425B/no
Publication of NO177425C publication Critical patent/NO177425C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO901494A 1989-04-03 1990-04-02 Analogifremgangsmåte for fremstilling av terapeutisk aktive interfenylen-7-oksabicyklo-heptyl-substituerte heterocykliske amid-prostaglandinanaloger NO177425C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33407089A 1989-04-03 1989-04-03

Publications (4)

Publication Number Publication Date
NO901494D0 NO901494D0 (no) 1990-04-02
NO901494L NO901494L (no) 1990-10-04
NO177425B NO177425B (no) 1995-06-06
NO177425C true NO177425C (no) 1995-09-20

Family

ID=23305449

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901494A NO177425C (no) 1989-04-03 1990-04-02 Analogifremgangsmåte for fremstilling av terapeutisk aktive interfenylen-7-oksabicyklo-heptyl-substituerte heterocykliske amid-prostaglandinanaloger

Country Status (28)

Country Link
EP (1) EP0391652B1 (fr)
JP (1) JP2989213B2 (fr)
KR (1) KR0160508B1 (fr)
CN (1) CN1028529C (fr)
AT (1) ATE119903T1 (fr)
AU (1) AU632797B2 (fr)
CA (1) CA2012267C (fr)
CY (1) CY1851A (fr)
CZ (1) CZ285656B6 (fr)
DD (1) DD293353A5 (fr)
DE (1) DE69017735T2 (fr)
DK (1) DK0391652T3 (fr)
EG (1) EG19080A (fr)
ES (1) ES2069682T3 (fr)
FI (1) FI97543C (fr)
HK (1) HK110495A (fr)
HU (2) HUT54368A (fr)
IE (1) IE67274B1 (fr)
IL (1) IL93771A (fr)
MX (1) MX20132A (fr)
MY (1) MY106245A (fr)
NO (1) NO177425C (fr)
NZ (1) NZ232897A (fr)
PL (1) PL164345B1 (fr)
PT (1) PT93641B (fr)
RU (1) RU2059618C1 (fr)
SK (1) SK158290A3 (fr)
ZA (1) ZA902559B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions
US4977174A (en) * 1989-06-12 1990-12-11 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
ZA911453B (en) * 1990-03-19 1991-11-27 Squibb & Sons Inc Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation
US5290799A (en) * 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5550248A (en) * 1990-11-29 1996-08-27 E.R. Squibb & Sons, Inc. Substituted stryl heterocyclic amido prostaglandin analogs
US5135939A (en) * 1991-01-28 1992-08-04 E. R. Squibb & Sons, Inc. Heterocyclic ketone prostaglandin analogs
US5238951A (en) * 1991-02-01 1993-08-24 E. R. Squibb & Sons, Inc. Heterocyclic amido prostaglandin analogs
IE920039A1 (en) * 1991-02-01 1992-08-12 Squibb & Sons Inc Heterocyclic amido prostaglandin analogs
US5158967A (en) * 1991-06-12 1992-10-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5162352A (en) * 1991-08-22 1992-11-10 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs
CA2081679A1 (fr) * 1991-11-27 1993-05-28 Raj N. Misra Analogues de prostaglandines amidiques heterocycliques de type pem-dialkyl-7-oxabicycloheptyle substitues utiles dans le traitement des thromboses et des spasmes vasculaires
US5281716A (en) * 1992-06-18 1994-01-25 Bristol-Myers Squibb Company Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds
US5399725A (en) * 1993-05-27 1995-03-21 Bristol-Myers Squibb Co. 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same
US5539126A (en) * 1994-04-20 1996-07-23 Bristol-Myers Squibb Company Method for preparing homochiral maleimide intermediates, via silylation techniques
US5849766A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Carbamoyl substituted heterocycles
US5849922A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Preparation of substituted alkenoic acids
US5856584A (en) * 1997-08-06 1999-01-05 The Nutrasweet Company Preparation of 3,3-dimethylbutyraldehyde by oxidation of 3, 3-dimethylbutanol
US5905175A (en) * 1998-05-20 1999-05-18 The Nutrasweet Company Synthesis and purification of 3,3-dimethylbutyraldehyde via oxidation of 1-chloro-3,3-dimethylbutane with dimethyl sulfoxide
US6407250B1 (en) 2000-09-14 2002-06-18 Allergan Sales, Inc. Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
US6511999B2 (en) 2000-09-14 2003-01-28 Allergan, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
US6369089B1 (en) 2000-09-14 2002-04-09 Allergan Sales, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US7045634B2 (en) 2003-09-05 2006-05-16 Allergan, Inc. Prostamide receptor antagonists
AU2010232556A1 (en) 2009-04-02 2011-11-03 Allergan, Inc. Prostaglandin E receptor antagonists
CA2837300A1 (fr) * 2011-05-25 2012-11-29 Allergan, Inc. Inhibiteurs d'hydrolase d'amide d'acide gras destines a traiter la douleur

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652576A (en) * 1985-10-18 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide-carbamate prostaglandin analogs
US4663337A (en) * 1986-04-18 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amides useful in the treatment of thrombotic disease
CA2006355A1 (fr) * 1988-12-23 1990-06-23 Philip M. Sher Amide heterocyclique de 7-oxabicycloheptyl substitue analogues de la prostaglandine utiles dans le traitement des affections thrombotiques et vasospastiques
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions

Also Published As

Publication number Publication date
SK278865B6 (sk) 1998-04-08
HU9002048D0 (en) 1990-08-28
FI901645A0 (fi) 1990-04-02
ES2069682T3 (es) 1995-05-16
CA2012267C (fr) 2001-02-27
AU632797B2 (en) 1993-01-14
EG19080A (en) 1994-07-30
ZA902559B (en) 1991-01-30
IL93771A (en) 1995-06-29
CN1046163A (zh) 1990-10-17
PT93641A (pt) 1990-11-20
DD293353A5 (de) 1991-08-29
DK0391652T3 (da) 1995-04-03
CA2012267A1 (fr) 1990-10-03
CZ158290A3 (cs) 1999-06-16
NO177425B (no) 1995-06-06
MY106245A (en) 1995-04-29
ATE119903T1 (de) 1995-04-15
HU210713A9 (en) 1995-06-28
EP0391652B1 (fr) 1995-03-15
AU5206490A (en) 1990-10-04
CY1851A (en) 1996-03-08
KR0160508B1 (ko) 1998-12-01
JPH02289579A (ja) 1990-11-29
RU2059618C1 (ru) 1996-05-10
KR900016197A (ko) 1990-11-12
NZ232897A (en) 1992-12-23
PL284600A1 (en) 1991-01-14
DE69017735D1 (de) 1995-04-20
NO901494L (no) 1990-10-04
SK158290A3 (en) 1998-04-08
IE901095L (en) 1990-10-03
JP2989213B2 (ja) 1999-12-13
HUT54368A (en) 1991-02-28
CN1028529C (zh) 1995-05-24
IL93771A0 (en) 1990-12-23
CZ285656B6 (cs) 1999-10-13
FI97543C (fi) 1997-01-10
NO901494D0 (no) 1990-04-02
HK110495A (en) 1995-07-14
PL164345B1 (pl) 1994-07-29
MX20132A (es) 1994-01-31
DE69017735T2 (de) 1995-08-17
PT93641B (pt) 1996-06-28
IE67274B1 (en) 1996-03-20
EP0391652A1 (fr) 1990-10-10
FI97543B (fi) 1996-09-30

Similar Documents

Publication Publication Date Title
NO177425C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive interfenylen-7-oksabicyklo-heptyl-substituerte heterocykliske amid-prostaglandinanaloger
EP0577847A4 (fr) Derive de morphinane et utilisation en medicine.
DE3683711D1 (de) Substituierte verbrueckte diabicycloalkylchinoloncarbonsaeure.
DE69010139D1 (de) Haarkräftigungsmittel.
EP0156603A3 (en) 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
EP0535928A3 (en) Process for producing intermediates for use in production of alkoxyiminoacetamides and intermediates to be used therein
DE58900183D1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
DE68929227D1 (de) Antimikrobielle Quinolonyllactamester
BR8902929A (pt) Artigo vendavel
ES2094742T3 (es) Aminocarbonilcarbamatos relacionados con fisostigmina, un procedimiento para su preparacion y su uso como medicamentos.
PT86032A (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung
ES2014188A6 (es) Procedimiento de preparar acidos aceticos y sus derivados.
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
GR3015704T3 (en) Glycerin derivative and its pharmacological use.
ES2061749T3 (es) Compuestos heterociclicos y agentes antiulcerosos.
ATE100710T1 (de) Eperisone als hypotonikum.
ATE35679T1 (de) Verfahren zur herstellung von cis-3,3,5trimethylcyclohexyl-d,l-alpha-(3-pyridincarboxy - phenylacetat.